Anne Thomas

Anne Thomas has worked in the clinical operations field since 2001. Anne began their career at Memorial Sloan-Kettering Cancer Center as a Research Study Assistant in 2001. In 2004, they moved to ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, where they served as a Senior Clinical Research Associate. In 2008, they joined Genentech as a Global Study Leader. From 2011 to 2017, Anne Thomas worked at Gilead Sciences in various roles, including Associate Director, Senior Clinical Program Manager, and Clinical Program Manager. Most recently, Anne Thomas joined Five Prime Therapeutics, Inc. in 2017, where they held the positions of Executive Director, Senior Director, and Director. In 2021, they were appointed Vice President Clinical Operations at Enliven Therapeutics.

Anne Thomas attended Georgetown University from 1997 to 2001, where they earned a Bachelor of Science degree in Biology.